Found: 7
Select item for more details and to access through your institution.
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02665-6
- By:
- Publication type:
- Article
Intrathecal Baclofen in Hereditary Spastic Paraparesis.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00901
- By:
- Publication type:
- Article
On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study.
- Published in:
- Brain & Behavior, 2022, v. 12, n. 5, p. 1, doi. 10.1002/brb3.2566
- By:
- Publication type:
- Article
Eleven years’ experience with Intrathecal Baclofen – Complications, risk factors.
- Published in:
- Brain & Behavior, 2018, v. 8, n. 5, p. 1, doi. 10.1002/brb3.965
- By:
- Publication type:
- Article
Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2023, v. 280, n. 11, p. 5115, doi. 10.1007/s00405-023-08163-x
- By:
- Publication type:
- Article
Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 6, p. 1685, doi. 10.1111/ene.15307
- By:
- Publication type:
- Article
Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple Sclerosis.
- Published in:
- Journal of Central Nervous System Disease, 2022, p. 1, doi. 10.1177/11795735221084837
- By:
- Publication type:
- Article